Dexamethasone and enalapril suppress intimal hyperplasia individually but have no synergistic effect

Annals of Vascular Surgery

Volumn 12, Issue 3, 1998, Pages 216-220

  Petrik, Pavel V ^a   Law, Michael M ^a   Moore, Wesley S ^a   Colburn, Michael D ^a   Quiñones Baldrich, William ^a   Gelabert, Hugh A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON CATHETER; CAROTID ARTERY; CONTROLLED STUDY; DRUG POTENTIATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0031899647     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100169900143     Document Type: Article

References (26)

1. Simpson J, Baim D, Hinohara T, Cowley M, Smucker M, Group UDCI. Restenosis of de novo lesions in native coronary arteries following directional coronary atherectomy: Mullicenter experience. Abstract. J Am Coll Cardiol 1991; 17:346A.
2. Clowes A, Schwartz S. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res 1985;58:839-845.
3. Herrman J, Hermans W, Vos J, Serruys P. Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? Drugs 1993;46:18-52.
4. Clowes A, Clowes M. Kinetics of cellular proliferation after arterial injury. I.V. heparin inhibits rat smooth muscle mitogenesis and migration. Circ Res 1986;58:839-845.
5. Clowes A, Karnovsky M. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 1977; 265:625-626.
6. Majesky M, Schwartz S, Clowes M, Clowes A. Heparin regulates smooth muscle S-phase entry in the injured rat carotid artery. Circ Res 1987;61:296-300.
7. Stein B, Fuster V, Israel D, Cohen M, Badimon L. Platelet inhibitor agents in Cardiovascular disease: An update. J Am Coll Cardiol 1989;14:813-836.
8. Owens G. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension 1987;9:178-187.
9. Daemen M, Lombardi D, Bosman F, Schwartz S. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991;68:450-456.
10. Naftilan A, Pratt R, Dazau V. Induction of platelet derived growth factor A chain and C-myc expressions by angiotensin II in culture rat vascular smooth muscle cells. J Clin Invest 1989;83:1419-1424.
11. Powell J, Clozel J, Muller R, Kuhn H, Hefti F. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-188.
12. Powell J, Rouge M, Muller R, Baumgartner H. Cilazapril suppresses myointimal proliferation after vascular injury: Effects of growth factor induction and vascular smooth muscle cells. Basic Res Cardiol 1991;86:65-74.
13. Scott-Burden T, Resink T, Hahn A, Buhler F. Induction of thrombospondin expression in vascular smooth muscle cells by angiotensin II. J Cardiovas Pharmacol 1990;16:17-20.
14. Grines C, Rizik D, Levine A, Schreiber T, Gangadharan V. Colchicine angioplasty restenosis trial (CART). Abstract. Circulation 1991;84:II-365.
15. Currier J, Pow T, Minihan A, Haudenschild C, Faxon D. Colchicine inhibits restenosis after iliac angioplasty in the atherosclerotic rabbit. Circulation 1989;80:11-66.
16. Villa A, Guzman L, Golomb G, Levy R, Topol E. Local delivery of dexamethasone for prevention of neointimal proliferation after balloon injury in the rat carotid model. J Am Coll Cardiol 1993;21:179A.
17. Rose T, Beauchamp B. Short term high dose steroid treatment to prevent restenosis in PTCA. Abstract. Circulation 1987;76:IV-371.
18. Pepine C, Hirshfeld J, Macdonald R, Henderson M, Bass T. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. Circulation 1990;81:1753-1761.
19. Colburn M, Moore W, Gelabert H, Quiñones-Baldrich W. Dose responsive suppression of myointimal hyperplasia by dexamethasone. J Vasc Surg 1992;15:510-518.
20. Petrik PV, Gelabert HA, Moore WS, Quiñones-Baldrich W. Pharmacologic suppression of intimai hyperplasia: a dose-response suppression by enalapril. Am Surgeon 1995; 61 (10):851-855.
21. Holm J, Hansson G. Cellular and immunologic features of carotid artery disease in man and experimental animal models. Eur J Vasc Surg 1990;4:49-55.
22. Powell J, Muller R, Rouge M, Kuhn H, Hefti F. The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. J Cardiol Pharmacol 1989;27:189S-197S.
23. MacDonald R, Panush R, Pepine C. Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1987;60: 56B-60B.
24. Berk B, Gordon J, Alexander R. Pharmacologic roles of heparin and glucocorticoids to prevent restenosis after coronary angioplasty. J Am Coll Cardiol 1991;17:111B-117B.
25. Freischlag J, Colburn M, Quiñones-Baldrich W, Moore W. Alteration of neutrophil (PMN) function by heparin, dexamethasone, and enalapril. J Surg Res 1992;52:523-529.
26. Gordon J, Berk B, Bettmann M, Selwyn A, Rennke H. Vascular smooth muscle proliferation following balloon injury is synergistically inhibited by low molecular weight heparin and hydrocortisone. Abstract. Circulation 1987;7.